Insights.

All Posts by Peter Vigliarolo

The Dual Threat of Flu and COVID-19: Why an Annual Flu Vaccine is More Important Than Ever, Especially for Adults with Chronic Health Conditions

Every influenza (flu) season is unpredictable. The typical refrain is “if you’ve seen one flu season, you’ve seen one flu season” no matter how many years you have worked in the space. The upc…
Read More

The Golden Rules of Communicating During a Public Health Crisis

When a disease outbreak or epidemic strikes, scores of companies, nonprofits and health groups want to make themselves heard. But the COVID-19 pandemic has turned daily life on its head and companies…
Read More

How Challenger Pharma Brands Can Connect With – And Leverage – Influencers

If a challenger brand announces a new drug and no one notices, did it really launch? The pharma industry is crowded. Without a strategic plan, challenger brands risk drowning in a sea of competitors a…
Read More

Here to stay: turning launch milestones into momentum

Making a big splash in the market during a product launch is good – but creating a lasting presence in the market is better. As a pharma brand, the worst thing you can do after a launch is … nothi…
Read More

The Challenge Of Marketing A Pharmaceutical Drug In A Price-Sensitive Environment

“How much does it cost?” Often one of the first questions that come to mind for pharma customers (right behind, “Does it work?”), and a good indicator of the pharma market’s struggle with pr…
Read More

How ROA expectations can impact pharma marketing strategies beyond your program’s specific ROI

ROA – or return on assets – is often a term reserved for business analysts or investors. However, it should be in every pharma marketer’s vocabulary too. Yes, ROA can guide important business ma…
Read More